MG50.24

ICD-11 MMS 2026-01

Carbapenem resistant Escherichia coli

Coding note

These categories should never be used in primary coding. The codes are provided for use as supplementary or additional codes when it is desired to identify the resistance, non-responsiveness and refractive properties of a condition to antimicrobials.

Coding note from above levels

These categories should never be used in primary coding. The codes are provided for use as supplementary or additional codes when it is desired to identify the resistance, non-responsiveness and refractive properties of a condition to antimicrobials. In case of multiple resistances, code each one separately if listed below.

Index terms

  • Carbapenem resistant Escherichia coli
  • Doripenem resistant Escherichia coli
  • Ertapenem resistant Escherichia coli
Show allHide
  • Imipenem resistant Escherichia coli
  • Meropenem resistant Escherichia coli

Exclusions from above levels

  • 19 – Certain conditions originating in the perinatal period
  • JA66 – Clinical findings on antenatal screening of mother

Sibling codes

  • MG50.20 – Sulfonamide or trimethoprim resistant Escherichia coli
  • MG50.21 – Fluoroquinolone resistant Escherichia coli
  • MG50.22 – Third generation cephalosporin resistant Escherichia coli
  • MG50.23 – Fourth-generation cephalosporins resistant Escherichia coli
  • MG50.25 – Polymyxin resistant Escherichia coli
  • MG50.26 – Penicillin resistant Escherichia coli
  • MG50.27 – Extended spectrum beta-lactamase producing Escherichia coli
  • MG50.2Y – Escherichia coli resistant to other antibiotic
  • MG50.2Z – Escherichia coli resistant to unspecified antibiotic

Foundation entity

Carbapenem resistant Escherichia coli – http://id.who.int/icd/entity/146561458

Part of: MG50.2: Antibiotic resistant Escherichia coli › MG50: Finding of gram negative bacteria resistant to antimicrobial drugs › 21: Symptoms, signs or clinical findings, not elsewhere classified